Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2012

4257 ARTíCULOS , VIENDO DEL 76 AL 90

PUBMED

Brain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson's disease.

Ravid R, Ferrer I.

FEBS J. 2012 Apr;279(7):1167-76. doi: 10.1111/j.1742-4658.2012.08518.x. Review.

0

0

0

PUBMED

[New aspects of Parkinson disease: introduction].

Hirata K.

Brain Nerve. 2012 Apr;64(4):317-8. Japanese. No abstract available.

0

0

0

PUBMED

Echoes from childhood--imitation in Gilles de la Tourette Syndrome.

Finis J, Moczydlowski A, Pollok B, Biermann-Ruben K, Thomalla G, Heil M, Krause H, Jonas M, Schnitzler A, Münchau A.

Mov Disord. 2012 Apr;27(4):562-5. doi: 10.1002/mds.24913.

0

0

0

PUBMED

Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.

Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH.

Brain. 2012 Jul;135(Pt 7):2058-73. doi: 10.1093/brain/aws133.

0

0

0

PUBMED

Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.

Carroll CB, Zeissler ML, Hanemann CO, Zajicek JP.

Neuropathol Appl Neurobiol. 2012 Oct;38(6):535-47. doi: 10.1111/j.1365-2990.2011.01248.x.

0

0

0

PUBMED

Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons.

Khasnavis S, Pahan K.

J Neuroimmune Pharmacol. 2012 Jun;7(2):424-35. doi: 10.1007/s11481-011-9286-3.

0

0

0

PUBMED

Apathy: a complex symptom specific to the clinical pattern of presentation of Parkinson's disease?

Moretti R, Torre P, Antonello RM, Rosin MV, Esposito F, Furman MR, Bellini G.

Am J Alzheimers Dis Other Demen. 2012 May;27(3):196-201. doi: 10.1177/1533317512445502.

0

0

0

PUBMED

Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.

Belin AC, Ran C, Anvret A, Paddock S, Westerlund M, Håkansson A, Nissbrandt H, Söderkvist P, Dizdar N, Ahmadi A, Anvret M, Willows T, Sydow O, Galter D.

Neurosci Lett. 2012 Jul 26;522(1):30-5. doi: 10.1016/j.neulet.2012.06.007.

0

0

0

PUBMED

Beyond the Burke-Fahn-Marsden Dystonia Rating Scale: deep brain stimulation in childhood secondary dystonia.

Gimeno H, Tustin K, Selway R, Lin JP.

Eur J Paediatr Neurol. 2012 Sep;16(5):501-8. doi: 10.1016/j.ejpn.2011.12.014.

0

0

0

PUBMED

Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3.

Siebert M, Donis KC, Socal M, Rieder CR, Emmel VE, Vairo F, Michelin-Tirelli K, França M Jr, D'Abreu AC, Bettencourt C, Lima M, Lopes Cendes I, Saraiva-Pereira ML, Jardim LB.

Parkinsonism Relat Disord. 2012 Feb;18(2):185-90. doi: 10.1016/j.parkreldis.2011.09.024.

0

0

0

PUBMED

Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease.

Ueda Y, Tokashiki S, Kanemaru A, Kojima T.

Biochem Biophys Res Commun. 2012 Nov 23;428(3):401-4. doi: 10.1016/j.bbrc.2012.10.067.

0

0

0

PUBMED

Modeling movement disorders--CRPS-related dystonia explained by abnormal proprioceptive reflexes.

Mugge W, Munts AG, Schouten AC, van der Helm FC.

J Biomech. 2012 Jan 3;45(1):90-8. doi: 10.1016/j.jbiomech.2011.09.024.

0

0

0

PUBMED

Pharmacokinetics of levodopa/carbidopa delivered from gastric-retentive extended-release formulations in patients with Parkinson's disease.

Chen C, Cowles VE, Sweeney M, Stolyarov ID, Illarioshkin SN.

J Clin Pharmacol. 2012 Jul;52(7):1069-77. doi: 10.1177/0091270011409232.

0

0

0

PUBMED

Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.

Ballanger B, Klinger H, Eche J, Lerond J, Vallet AE, Le Bars D, Tremblay L, Sgambato-Faure V, Broussolle E, Thobois S.

Mov Disord. 2012 Jan;27(1):84-9. doi: 10.1002/mds.23895.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy